rs202207965
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_018368.4(LMBRD1):c.981-3del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,541,308 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_018368.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LMBRD1 | NM_018368.4 | c.981-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000649934.3 | |||
LMBRD1 | NM_001363722.2 | c.762-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ||||
LMBRD1 | NM_001367271.1 | c.762-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ||||
LMBRD1 | NM_001367272.1 | c.762-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LMBRD1 | ENST00000649934.3 | c.981-3del | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NM_018368.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000198 AC: 30AN: 151466Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000116 AC: 161AN: 1389724Hom.: 0 Cov.: 23 AF XY: 0.0000950 AC XY: 66AN XY: 694582
GnomAD4 genome AF: 0.000198 AC: 30AN: 151584Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74080
ClinVar
Submissions by phenotype
Methylmalonic aciduria and homocystinuria type cblF Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 17, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at